For the Inventor, By the Inventor

Enter assignee name

Anderlecht, Belgium

Ogeda Sa

USPTO Granted Patents = 23

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 19

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Hamid R Hoveyda (23 out of 51 patents)

Graeme Lovat Fraser (18 out of 38 patents)

Guillaume Dutheuil (16 out of 23 patents)

4. Marie-Odile Roy (6 out of 10 patents)

5. Didier Schils (3 out of 7 patents)

6. Ludivine Zoute (3 out of 7 patents)

7. Julien Parcq (3 out of 9 patents)

8. Frederic Batt (3 out of 4 patents)

9. Mohamed El Bousmaqui (2 out of 3 patents)

10. Jerome Bernard (1 out of 1 patent)

11. Mohamed E Bousmaqui (1 out of 1 patent)

12. Marie-Odile Roy (0 patent)

23 patents: Sort by Forward Citations

1. 12458641 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2025-11-04),

2. 12162849 - Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-deuterated form thereof (2024-12-10),

3. 11731974 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2023-08-22),

4. 11478472 - NK-3 receptor antagonists for therapeutic treatment of leptin-related disease (2022-10-25),

5. 11078203 - Deuterated fezolinetant (2021-08-03),

6. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2021-03-09),

7. 10836768 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2020-11-17),

8. 10787458 - Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines (2020-09-29),

9. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2020-06-16),

10. 10624890 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2020-04-21),

11. 10544150 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2020-01-28),

12. 10214533 - N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2019-02-26),

13. 10183948 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2019-01-22),

14. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2018-09-04),

15. 10065960 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2018-09-04),

Ogeda SA is a biopharmaceutical company specializing in the development of innovative drug candidates targeting debilitating women's health disorders. With a strong emphasis on research and development, Ogeda aims to improve the lives of women by providing novel and effective treatment options. Utilizing cutting-edge technology and scientific expertise, Ogeda is committed to advancing therapeutic solutions for conditions such as endometriosis, polycystic ovary syndrome, and uterine fibroids. For more information about Ogeda and its mission, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

23 Patents

#1 in Anderlecht

#146 in Belgium

#27,581 in the World

Anderlecht, Belgium

Ogeda Sa

Forward Citations = 19

11 inventors:

Hamid R Hoveyda (23 out of 51 patents)

Graeme Lovat Fraser (18 out of 38 patents)

Guillaume Dutheuil (16 out of 23 patents)

4. Marie-Odile Roy (6 out of 10 patents)

5. Didier Schils (3 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…